Next, the successful in vivo tests of FH-IgG chimeric proteins in bacterial infections, indicate that there might lie success in similar approaches using C4BP, C1-INH or Vn, which all are used by bacteria in complement evasion mechanisms (19). Here, VTN is linked to bacterial infectious disease.